AbbVie (ABBV) Minority Interest (2020 - 2026)

AbbVie (ABBV) has 7 years of Minority Interest data on file, last reported at $44.0 million in Q1 2026.

• Minority Interest for Q1 2026 came in at $44.0 million, up 4.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $44.0 million (up 4.76% YoY), and the FY2025 annual result was $42.0 million, up 7.69% from the prior year.
• Minority Interest rose to $44.0 million in Q1 2026 per ABBV's latest filing, from $42.0 million in the prior quarter.
• Over five years, Minority Interest peaked at $45.0 million in Q2 2025 and troughed at $29.0 million in Q1 2023.
• A 5-year average of $37.8 million and a median of $39.0 million in 2024 frame the typical range for Minority Interest.
• The sharpest annual moves came in 2022 and 2023: Minority Interest soared 40.0% in 2022, then slipped 8.57% in 2023.
• A 5-year view of Minority Interest shows it stood at $33.0 million in 2022, then climbed by 12.12% to $37.0 million in 2023, then increased by 5.41% to $39.0 million in 2024, then increased by 7.69% to $42.0 million in 2025, then increased by 4.76% to $44.0 million in 2026.
• Business Quant data shows ABBV's Minority Interest at $44.0 million in Q1 2026, $42.0 million in Q4 2025, and $43.0 million in Q3 2025.